COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants-Reference-Cited by-同舟云学术

COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants

Published:2022-06 Issue:6 Volume:25 Page:104457
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Wussow Felix,Kha Mindy,Faircloth Katelyn,Nguyen Vu H.,Iniguez Angelina,Martinez Joy,Park Yoonsuh,Nguyen Jenny,Kar Swagata,Andersen Hanne,Lewis Mark G.,Chiuppesi Flavia,Diamond Don J.^ORCID

Funder

U.S. Public Health Service

City of Hope National Medical Center

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference58 articles.

1. Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: a phase 2, randomized clinical trial;Aldoss;Ann. Intern. Med.,2020

2. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) Variant;Andrews;N. Engl. J. Med.,2022

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

4. Activity of convalescent and vaccine serum against SARS-CoV-2 omicron;Carreno;Nature,2021

5. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden syrian hamster model: implications for disease pathogenesis and transmissibility;Chan;Clin. Infect. Dis.,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus;Communications Medicine;2024-02-16

2. Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates;Frontiers in Immunology;2023-12-12

3. Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters;Frontiers in Immunology;2023-10-18

4. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy;Vaccines;2023-09-15

5. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases;Journal of Molecular Biology;2023-08